{"id":900,"date":"2026-03-16T10:23:48","date_gmt":"2026-03-16T09:23:48","guid":{"rendered":"https:\/\/studienportal-gyn.de\/positive-results-from-the-duo-o-study\/"},"modified":"2026-07-21T11:13:19","modified_gmt":"2026-07-21T09:13:19","slug":"positive-results-from-the-duo-o-study","status":"publish","type":"post","link":"https:\/\/studienportal-gyn.de\/en\/positive-results-from-the-duo-o-study\/","title":{"rendered":"Positive results from the DUO-O study!"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"900\" class=\"elementor elementor-900 elementor-654\">\n\t\t\t\t<div class=\"elementor-element elementor-element-75fe1a8 e-flex e-con-boxed e-con e-parent\" data-id=\"75fe1a8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0d6ba3c elementor-widget elementor-widget-text-editor\" data-id=\"0d6ba3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2><span class=\"BZ_Pyq_fadeIn\">New <\/span><span class=\"BZ_Pyq_fadeIn\">Combination Therapy <\/span><span class=\"BZ_Pyq_fadeIn\">for <\/span><span class=\"BZ_Pyq_fadeIn\">advanced <\/span><span class=\"BZ_Pyq_fadeIn\">ovarian cancer <\/span><span class=\"BZ_Pyq_fadeIn\">under investigation<\/span><\/h2><p data-start=\"248\" data-end=\"508\"><span class=\"BZ_Pyq_fadeIn\">The  <\/span><span class=\"BZ_Pyq_fadeIn\">international  <\/span><strong data-start=\"268\" data-end=\"294\"><span class=\"BZ_Pyq_fadeIn\">Phase-<\/span><span class=\"BZ_Pyq_fadeIn\">Phase 3<\/span><span class=\"BZ_Pyq_fadeIn\">Study (<\/span><span class=\"BZ_Pyq_fadeIn\">DUO-<\/span><span class=\"BZ_Pyq_fadeIn\">O)<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">has <\/span><span class=\"BZ_Pyq_fadeIn\">examined, <\/span><span class=\"BZ_Pyq_fadeIn\">whether <\/span><span class=\"BZ_Pyq_fadeIn\">a <\/span><span class=\"BZ_Pyq_fadeIn\">combination <\/span><span class=\"BZ_Pyq_fadeIn\">of <\/span><strong data-start=\"335\" data-end=\"416\"><span class=\"BZ_Pyq_fadeIn\">immunotherapy, <\/span><span class=\"BZ_Pyq_fadeIn\">chemotherapy, <\/span><span class=\"BZ_Pyq_fadeIn\">targeted <\/span><span class=\"BZ_Pyq_fadeIn\">therapy <\/span><span class=\"BZ_Pyq_fadeIn\">and <\/span><span class=\"BZ_Pyq_fadeIn\">maintenance therapy<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">that <\/span><span class=\"BZ_Pyq_fadeIn\">progress <\/span><span class=\"BZ_Pyq_fadeIn\">of <\/span><strong><span class=\"BZ_Pyq_fadeIn\">newly <\/span><span class=\"BZ_Pyq_fadeIn\">diagnosed <\/span><span class=\"BZ_Pyq_fadeIn\">advanced <\/span><span class=\"BZ_Pyq_fadeIn\">ovarian cancer <\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">delay <\/span><span class=\"BZ_Pyq_fadeIn\">.<\/span><\/p><p data-start=\"510\" data-end=\"863\"><span class=\"BZ_Pyq_fadeIn\">To <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">study <\/span><span class=\"BZ_Pyq_fadeIn\">measures <\/span><span class=\"BZ_Pyq_fadeIn\">more than <\/span><span class=\"BZ_Pyq_fadeIn\">1,100 <\/span><span class=\"BZ_Pyq_fadeIn\">female patients<\/span> <span class=\"BZ_Pyq_fadeIn\">took part, <\/span><span class=\"BZ_Pyq_fadeIn\">whose <\/span><span class=\"BZ_Pyq_fadeIn\">tumor <\/span><strong data-start=\"577\" data-end=\"600\"><span class=\"BZ_Pyq_fadeIn\">no <\/span><span class=\"BZ_Pyq_fadeIn\">BRCA<\/span><span class=\"BZ_Pyq_fadeIn\">mutation<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">showed.  <\/span><span class=\"BZ_Pyq_fadeIn\">All  <\/span><span class=\"BZ_Pyq_fadeIn\">received  <\/span><span class=\"BZ_Pyq_fadeIn\">First of all  <\/span><span class=\"BZ_Pyq_fadeIn\">the  <\/span><span class=\"BZ_Pyq_fadeIn\">Standard Treatment  <\/span><span class=\"BZ_Pyq_fadeIn\">with  <\/span><span class=\"BZ_Pyq_fadeIn\">Carboplatin  <\/span><span class=\"BZ_Pyq_fadeIn\">and  <\/span><span class=\"BZ_Pyq_fadeIn\">Paclitaxel<\/span><span class=\"BZ_Pyq_fadeIn\">,  <\/span><span class=\"BZ_Pyq_fadeIn\">frequently  <\/span><span class=\"BZ_Pyq_fadeIn\">combined  <\/span><span class=\"BZ_Pyq_fadeIn\">with  <\/span><span class=\"BZ_Pyq_fadeIn\">the  <\/span><span class=\"BZ_Pyq_fadeIn\">Antibodies  <\/span><span class=\"BZ_Pyq_fadeIn\">Bevacizumab<\/span><span class=\"BZ_Pyq_fadeIn\">.  <\/span><span class=\"BZ_Pyq_fadeIn\">Next,  <\/span><span class=\"BZ_Pyq_fadeIn\">were  <\/span><span class=\"BZ_Pyq_fadeIn\">various  <\/span><span class=\"BZ_Pyq_fadeIn\">additional  <\/span><span class=\"BZ_Pyq_fadeIn\">Combination Therapies  <\/span><span class=\"BZ_Pyq_fadeIn\">Tested.<\/span><\/p><h3 data-section-id=\"1ivncoi\" data-start=\"865\" data-end=\"900\"><span class=\"BZ_Pyq_fadeIn\">Key Findings <\/span><span class=\"BZ_Pyq_fadeIn\">finding <\/span><span class=\"BZ_Pyq_fadeIn\">of the <\/span><span class=\"BZ_Pyq_fadeIn\">study<\/span><\/h3><p data-start=\"901\" data-end=\"1153\"><span class=\"BZ_Pyq_fadeIn\">The <\/span><span class=\"BZ_Pyq_fadeIn\">combination <\/span><span class=\"BZ_Pyq_fadeIn\">of <\/span><strong data-start=\"923\" data-end=\"983\"><span class=\"BZ_Pyq_fadeIn\">durvalumab (<\/span><span class=\"BZ_Pyq_fadeIn\">immunotherapy) + <\/span><span class=\"BZ_Pyq_fadeIn\">chemotherapy + <\/span><span class=\"BZ_Pyq_fadeIn\">Bevacizumab<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">, <\/span><span class=\"BZ_Pyq_fadeIn\">followed <\/span><span class=\"BZ_Pyq_fadeIn\">by <\/span><span class=\"BZ_Pyq_fadeIn\">a <\/span><strong data-start=\"1003\" data-end=\"1085\"><span class=\"BZ_Pyq_fadeIn\">maintenance therapy <\/span><span class=\"BZ_Pyq_fadeIn\">with <\/span><span class=\"BZ_Pyq_fadeIn\">durvalumab, <\/span><span class=\"BZ_Pyq_fadeIn\">Bevacizumab <\/span><span class=\"BZ_Pyq_fadeIn\">and <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">PARP<\/span><span class=\"BZ_Pyq_fadeIn\">inhibitor <\/span><span class=\"BZ_Pyq_fadeIn\">olaparib<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">, <\/span><span class=\"BZ_Pyq_fadeIn\">was able to <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><strong data-start=\"1098\" data-end=\"1152\"><span class=\"BZ_Pyq_fadeIn\">progression <\/span><span class=\"BZ_Pyq_fadeIn\">of <\/span><span class=\"BZ_Pyq_fadeIn\">disease <\/span><span class=\"BZ_Pyq_fadeIn\">significantly <\/span><span class=\"BZ_Pyq_fadeIn\">significantly<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">.<\/span><\/p><ul data-start=\"1155\" data-end=\"1546\"><li data-section-id=\"10h344y\" data-start=\"1155\" data-end=\"1332\"><p data-start=\"1157\" data-end=\"1332\"><span class=\"BZ_Pyq_fadeIn\">In the case of <\/span><span class=\"BZ_Pyq_fadeIn\">all <\/span><span class=\"BZ_Pyq_fadeIn\">female patients <\/span><span class=\"BZ_Pyq_fadeIn\">without <\/span><span class=\"BZ_Pyq_fadeIn\">BRCA<\/span><span class=\"BZ_Pyq_fadeIn\">mutation <\/span><span class=\"BZ_Pyq_fadeIn\">remained <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">disease <\/span><span class=\"BZ_Pyq_fadeIn\">in <\/span><span class=\"BZ_Pyq_fadeIn\">on average <\/span><strong data-start=\"1230\" data-end=\"1252\"><span class=\"BZ_Pyq_fadeIn\">24.2 <\/span><span class=\"BZ_Pyq_fadeIn\">months <\/span><span class=\"BZ_Pyq_fadeIn\">stable<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">, <\/span><span class=\"BZ_Pyq_fadeIn\">compared <\/span><span class=\"BZ_Pyq_fadeIn\">to <\/span><strong data-start=\"1273\" data-end=\"1289\"><span class=\"BZ_Pyq_fadeIn\">19.3 <\/span><span class=\"BZ_Pyq_fadeIn\">months<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">under <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">previous <\/span><span class=\"BZ_Pyq_fadeIn\">standard treatment.<\/span><\/p><\/li><li data-section-id=\"1ej8njk\" data-start=\"1333\" data-end=\"1546\"><p data-start=\"1335\" data-end=\"1546\"><span class=\"BZ_Pyq_fadeIn\">Especially <\/span><span class=\"BZ_Pyq_fadeIn\">clear <\/span><span class=\"BZ_Pyq_fadeIn\">was <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">effect <\/span><span class=\"BZ_Pyq_fadeIn\">in <\/span><span class=\"BZ_Pyq_fadeIn\">female patients <\/span><span class=\"BZ_Pyq_fadeIn\">with <\/span><span class=\"BZ_Pyq_fadeIn\">a <\/span><span class=\"BZ_Pyq_fadeIn\">so-called <\/span><strong data-start=\"1408\" data-end=\"1439\"><span class=\"BZ_Pyq_fadeIn\">HRD<\/span><span class=\"BZ_Pyq_fadeIn\">positive <\/span><span class=\"BZ_Pyq_fadeIn\">tumor biology<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">: <\/span><span class=\"BZ_Pyq_fadeIn\">Here <\/span><span class=\"BZ_Pyq_fadeIn\">it lay <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">time <\/span><span class=\"BZ_Pyq_fadeIn\">until <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">progress <\/span><span class=\"BZ_Pyq_fadeIn\">in <\/span><strong data-start=\"1485\" data-end=\"1505\"><span class=\"BZ_Pyq_fadeIn\">over <\/span><span class=\"BZ_Pyq_fadeIn\">three <\/span><span class=\"BZ_Pyq_fadeIn\">years<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">.<\/span><\/p><\/li><\/ul><p data-start=\"1548\" data-end=\"1664\"><span class=\"BZ_Pyq_fadeIn\">The <\/span><span class=\"BZ_Pyq_fadeIn\">treatment <\/span><span class=\"BZ_Pyq_fadeIn\">with <\/span><strong data-start=\"1567\" data-end=\"1588\"><span class=\"BZ_Pyq_fadeIn\">durvalumab <\/span><span class=\"BZ_Pyq_fadeIn\">alone<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">in addition <\/span><span class=\"BZ_Pyq_fadeIn\">to <\/span><span class=\"BZ_Pyq_fadeIn\">standard therapy <\/span><span class=\"BZ_Pyq_fadeIn\">showed <\/span><span class=\"BZ_Pyq_fadeIn\">, however, <\/span><strong data-start=\"1636\" data-end=\"1661\"><span class=\"BZ_Pyq_fadeIn\">no <\/span><span class=\"BZ_Pyq_fadeIn\">clear <\/span><span class=\"BZ_Pyq_fadeIn\">benefit<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">.<\/span><\/p><h3 data-section-id=\"1xnqc22\" data-start=\"1666\" data-end=\"1691\"><span class=\"BZ_Pyq_fadeIn\">Survival <\/span><span class=\"BZ_Pyq_fadeIn\">still <\/span><span class=\"BZ_Pyq_fadeIn\">unclear<\/span><\/h3><p data-start=\"1692\" data-end=\"1972\"><span class=\"BZ_Pyq_fadeIn\">Whether <\/span><span class=\"BZ_Pyq_fadeIn\">this <\/span><span class=\"BZ_Pyq_fadeIn\">combination <\/span><span class=\"BZ_Pyq_fadeIn\">also <\/span><strong data-start=\"1718\" data-end=\"1752\"><span class=\"BZ_Pyq_fadeIn\">improve <\/span><span class=\"BZ_Pyq_fadeIn\">overall survival <\/span><span class=\"BZ_Pyq_fadeIn\">survival<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">,  <\/span><span class=\"BZ_Pyq_fadeIn\">is  <\/span><span class=\"BZ_Pyq_fadeIn\">currently  <\/span><span class=\"BZ_Pyq_fadeIn\">yet  <\/span><span class=\"BZ_Pyq_fadeIn\">not  <\/span><span class=\"BZ_Pyq_fadeIn\">Sure.  <\/span><span class=\"BZ_Pyq_fadeIn\">In  <\/span><span class=\"BZ_Pyq_fadeIn\">the  <\/span><span class=\"BZ_Pyq_fadeIn\">previous  <\/span><span class=\"BZ_Pyq_fadeIn\">Reports  <\/span><span class=\"BZ_Pyq_fadeIn\">was able to  <\/span><span class=\"BZ_Pyq_fadeIn\">yet  <\/span><strong data-start=\"1828\" data-end=\"1866\"><span class=\"BZ_Pyq_fadeIn\">none <\/span><span class=\"BZ_Pyq_fadeIn\">clear <\/span><span class=\"BZ_Pyq_fadeIn\">survival advantage<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">displayed <\/span><span class=\"BZ_Pyq_fadeIn\">, <\/span><span class=\"BZ_Pyq_fadeIn\">but <\/span><span class=\"BZ_Pyq_fadeIn\">are <\/span><span class=\"BZ_Pyq_fadeIn\">longer <\/span><span class=\"BZ_Pyq_fadeIn\">longer <\/span><span class=\"BZ_Pyq_fadeIn\">are needed.<\/span><\/p><h3 data-section-id=\"1df88k4\" data-start=\"1974\" data-end=\"1992\"><span class=\"BZ_Pyq_fadeIn\">Side Effects<\/span><\/h3><p data-start=\"1993\" data-end=\"2136\"><span class=\"BZ_Pyq_fadeIn\">The  <\/span><span class=\"BZ_Pyq_fadeIn\">Side Effects  <\/span><span class=\"BZ_Pyq_fadeIn\">corresponded to  <\/span><span class=\"BZ_Pyq_fadeIn\">in the  <\/span><span class=\"BZ_Pyq_fadeIn\">Essential  <\/span><span class=\"BZ_Pyq_fadeIn\">to which  <\/span><span class=\"BZ_Pyq_fadeIn\">the  <\/span><span class=\"BZ_Pyq_fadeIn\">individual  <\/span><span class=\"BZ_Pyq_fadeIn\">Medications  <\/span><span class=\"BZ_Pyq_fadeIn\">and  <\/span><span class=\"BZ_Pyq_fadeIn\">were  <\/span><span class=\"BZ_Pyq_fadeIn\">in total  <\/span><strong data-start=\"2092\" data-end=\"2135\"><span class=\"BZ_Pyq_fadeIn\">comparable <\/span><span class=\"BZ_Pyq_fadeIn\">to <\/span><span class=\"BZ_Pyq_fadeIn\">previous <\/span><span class=\"BZ_Pyq_fadeIn\">experiences<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">.<\/span><\/p><h3 data-section-id=\"7ecdqd\" data-start=\"2138\" data-end=\"2176\"><span class=\"BZ_Pyq_fadeIn\">What <\/span><span class=\"BZ_Pyq_fadeIn\">means <\/span><span class=\"BZ_Pyq_fadeIn\">that <\/span><span class=\"BZ_Pyq_fadeIn\">for <\/span><span class=\"BZ_Pyq_fadeIn\">patients?<\/span><\/h3><p data-start=\"2177\" data-end=\"2447\"><span class=\"BZ_Pyq_fadeIn\">The <\/span><span class=\"BZ_Pyq_fadeIn\">study <\/span><span class=\"BZ_Pyq_fadeIn\">shows <\/span><span class=\"BZ_Pyq_fadeIn\">that <\/span><span class=\"BZ_Pyq_fadeIn\">a <\/span><strong data-start=\"2205\" data-end=\"2257\"><span class=\"BZ_Pyq_fadeIn\">combination <\/span><span class=\"BZ_Pyq_fadeIn\">of <\/span><span class=\"BZ_Pyq_fadeIn\">immunotherapy <\/span><span class=\"BZ_Pyq_fadeIn\">and <\/span><span class=\"BZ_Pyq_fadeIn\">PARP<\/span><span class=\"BZ_Pyq_fadeIn\">inhibitor<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">in  <\/span><span class=\"BZ_Pyq_fadeIn\">the  <\/span><span class=\"BZ_Pyq_fadeIn\">Initial Treatment  <\/span><span class=\"BZ_Pyq_fadeIn\">of the  <\/span><span class=\"BZ_Pyq_fadeIn\">advanced  <\/span><span class=\"BZ_Pyq_fadeIn\">Ovarian cancer  <\/span><span class=\"BZ_Pyq_fadeIn\">that  <\/span><span class=\"BZ_Pyq_fadeIn\">Progress  <\/span><span class=\"BZ_Pyq_fadeIn\">the  <\/span><span class=\"BZ_Pyq_fadeIn\">Illness  <\/span><span class=\"BZ_Pyq_fadeIn\">possibly  <\/span><strong data-start=\"2366\" data-end=\"2403\"><span class=\"BZ_Pyq_fadeIn\">significantly <\/span><span class=\"BZ_Pyq_fadeIn\">longer <\/span><span class=\"BZ_Pyq_fadeIn\">delay <\/span><span class=\"BZ_Pyq_fadeIn\">can<\/span><\/strong><span class=\"BZ_Pyq_fadeIn\">, <\/span><span class=\"BZ_Pyq_fadeIn\">especially <\/span><span class=\"BZ_Pyq_fadeIn\">in <\/span><span class=\"BZ_Pyq_fadeIn\">certain <\/span><span class=\"BZ_Pyq_fadeIn\">tumor biology.<\/span><\/p><p data-start=\"2449\" data-end=\"2582\"><span class=\"BZ_Pyq_fadeIn\">Whether <\/span><span class=\"BZ_Pyq_fadeIn\">this <\/span><span class=\"BZ_Pyq_fadeIn\">treatment <\/span><span class=\"BZ_Pyq_fadeIn\">in the future <\/span><strong data-start=\"2475\" data-end=\"2504\"><span class=\"BZ_Pyq_fadeIn\">become <\/span><span class=\"BZ_Pyq_fadeIn\">in <\/span><span class=\"BZ_Pyq_fadeIn\">the <\/span><span class=\"BZ_Pyq_fadeIn\">first-line<\/span><\/strong> <span class=\"BZ_Pyq_fadeIn\">will, <\/span><span class=\"BZ_Pyq_fadeIn\">depends <\/span><span class=\"BZ_Pyq_fadeIn\">, however, <\/span><span class=\"BZ_Pyq_fadeIn\">on <\/span><span class=\"BZ_Pyq_fadeIn\">further <\/span><span class=\"BZ_Pyq_fadeIn\">analyses <\/span><span class=\"BZ_Pyq_fadeIn\">and <\/span><span class=\"BZ_Pyq_fadeIn\">approval decisions <\/span><span class=\"BZ_Pyq_fadeIn\">.<\/span><\/p><p data-start=\"2449\" data-end=\"2582\">Source: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41380962\/\" target=\"_blank\" rel=\"noopener\">Publication<\/a> (the article is in English)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>New Combination Therapy for advanced ovarian cancer under investigation The international Phase-Phase 3Study (DUO-O) has examined, whether a combination of immunotherapy, chemotherapy, targeted therapy and maintenance therapy that progress of newly diagnosed advanced ovarian cancer delay . To the study measures more than 1,100 female patients took part, whose tumor no BRCAmutation showed. All received [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":603,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,54],"tags":[],"class_list":["post-900","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-studies"],"acf":[],"_links":{"self":[{"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/posts\/900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/comments?post=900"}],"version-history":[{"count":1,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/posts\/900\/revisions"}],"predecessor-version":[{"id":901,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/posts\/900\/revisions\/901"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/media\/603"}],"wp:attachment":[{"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/media?parent=900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/categories?post=900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/studienportal-gyn.de\/en\/wp-json\/wp\/v2\/tags?post=900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}